2026 International Spring Forum
April 15, 2026 | 12:00 PM EST
Perspectives: Published Editorials and Industry Updates
Welcome to Perspectives, our blog designed to keep members, oncology stakeholders, and anyone interested in enhancing the care experience for oncology patients informed on critical issues. You’ll hear from thought leaders and learn about the impact and benefits of medically integrated pharmacy, operational insights designed to support you in the day-to-day delivery of care, as well as timely industry issues facing oncology pharmacy professionals.

Opportunity Awaits: Addressing the Unique Needs of Our Nation’s Veterans Diagnosed with Cancer
U.S. veterans with cancer often face delays and barriers to specialized care due to complex VA systems, rural access issues, and other challenges. The article calls for collaboration among providers, the VA, and policymakers to improve access and deliver timely, high-quality cancer treatment.
Celebrating a Decade of Impact: Member Spotlight on Dallas Lawry, DNP, FNP-C, AOCNP
As NCODA celebrates 10 years of advancing oncology care, we’re spotlighting the members who embody compassion and leadership in their work every day. Meet Dallas Rose Lawry, DNP, FNP-C, AOCNP, Pancreatic Cancer Nurse Practitioner at UC San Diego, whose personal journey through loss and resilience inspires her work leading a virtual diagnostic clinic and survivorship program for pancreatic cancer patients.

Celebrating a Decade of Impact: Member Spotlight on Andrew Ruplin, PharmD
As NCODA marks 10 years of advancing patient-centered oncology care, we’re spotlighting the members who make a difference every day. Meet Andrew Ruplin, PharmD of Fred Hutchinson Cancer Center and UW Medicine, whose dedication to patients and passion for innovation exemplify what it means to be part of the NCODA community. Read his story in our latest member spotlight.

Best Practices for Patient Management in Veteran Health
Cancer care within the Veterans Health Administration (VHA) is shaped by a unique patient population that requires integrated, evidence-based approaches. Veterans often have complex health histories, mental health concerns, and social barriers to care. These challenges demand not only medical expertise, but also a system of care that acknowledges the lived experiences and sacrifices of those who served.

Navigating a Cancer Journey with Communication and Coordination
August 14, 2025
Alabama Oncology shares how its medically integrated pharmacy model builds trust, streamlines care, and improves outcomes through constant communication, coordinated teams, and dedicated patient advocacy.

Serving Those Who Served: Delivering Oncology Care to Veterans
What does oncology care look like within the VA system—and how does it differ from the private sector? We recently sat down with former VA oncology pharmacist Nigina Ali, PharmD, to explore how care teams support Veterans through cancer treatment, the unique challenges they face, and the systems in place to meet their needs. Her firsthand insights shed light on both the strengths and the hurdles of delivering high-quality cancer care to those who served.

NCODA’s Leadership and Commitment to the Medically Integrated Oncology Care Team
NCODA has long championed patient-centered cancer care through its support of the Medically Integrated Pharmacy (MIP) model. From publishing national standards with ASCO to launching an MIP accreditation program, NCODA continues to create impactful resources that elevate the MIP model.

NCODA Perspective: Protecting Access to Oncology-Optimized Limited Distribution Drugs
June 26, 2025
Access to oncology-optimized limited distribution (OOLD) drugs is being increasingly threatened by shifting pharmacy benefit manager (PBM) practices that divert prescriptions away from medically integrated pharmacies (MIPs). NCODA is working with stakeholders to defend MIP access and safeguard oncology patients’ treatment journeys.

Coming Soon: Important OCE/IVE Updates
OCE and IVE sheets will soon be known as Patient Education Sheets — clearer, more consistent, and still rooted in the expert-backed information you rely on.

Optimizing Subcutaneous Therapy: Key Considerations and Collaborative Opportunities
June 23, 2025
The adoption of subcutaneous (SC) oncology therapies is increasing, offering benefits like shorter clinic visits, improved patient experience, and greater efficiency. However, challenges in administration techniques, equipment use, and workflow integration remain. NCODA’s oncology nursing experts are addressing these gaps through education, best practices, and collaborative partnerships to support consistent, high-quality SC therapy delivery.
